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Abstract 
We investigated the potential of a GC/Ei-MS method as an alternative to IRMS in breath 
13CO2 / 12CO2 analysis.  
 
Introduction 
Investigations on protein metabolism in humans can be performed with the isotope dilution 
technique[1]. This technique included priming with NaH13CO3 uses infusions of L-[1-
13C]Leucine (measured as 13C-Ketoisocaproic acid in blood samples) combined with 
identification of enrichments of  13CO2 in expired air samples. The enrichments of L-[1-
13C]Leucine and after analogous infusion of [6,6-2H2]glucose can be quantified by GC/MS-
PCI[2] and GC/MS-NCI[3] because of relatively high differences between baseline contents 
and steady state isotope ratios (1-4%)[4]. Usually the isotope ratio mass spectrometry (IRMS) 
is employed[5] to identify changes in the 13CO2 / 12CO2 ratio in expiratory breath samples. Its 
accuracy predestines the method because of the extremely small differences (about 0.005 
atom%) in 13C content in carbon dioxide[5] caused by 13C-enriched infusions. Earlier attempts 
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demonstrate the difficulties when other methods are used[6]. Nevertheless we tried to apply 
our gas chromatograph coupled to a mass selective detector (GC/MS-Ei) for the purpose of 
13CO2/12CO2 relation analysis.  
 
Experimental 
The stable isotope-enriched substance  L-[1-13C]Leucine was purchased from Euroiso-top 
(Saarbrücken, Germany). Expiratory air was sampled in 2 liter plastic bags and transferred 
into 5 ml Vacutainers (Bekton Dickinson, Plymouth, UK) with 50 ml glass syringes (popper 
& sons, New York, USA) to be sent to ISO Analytical Ltd. (Sandbach, Chesire, UK) for 
IRMS analysis with an Europa Scientific GSL/Geo 20/20. Sample preparation for GC/MS 
was also done by filling 50 ml glas syringes with expiratory air out of the plastic bags. To get 
storable samples 2 ml autosampler crimp vials (CZT, Kriftel, Germany) were overfilled about 
20 times by the glass syringes and immediately sealed.  
Statistical analysis was performed with GPOWER[7] and SPSS for Windows, version 10.0 
(SPSS Inc., Chicago, IL, USA). 
 
Chromatography 
Our chromatographic equipment was an Agilent 6890plus with an Agilent 5973 mass 
selective detector (Agilent, Waldbronn, Germany) in electronic ionisation (Ei) – single ion 
mode (sim) and a widebore GS-GASPRO column (30m*0.32mm) also from Agilent. A gas 
volume of 2.5µl was injected by an A200S autosampler (CTC-Analytics, Zwingen, 
Switzerland) with a 10µl Hamilton (Darmstadt, Germany) syringe into the SSL injector at 
265°C and a split ratio of 50:1. The oven was kept constant at 80°C with carrier gas 99.999 % 
pure helium (Linde, Hoellriegelskreut, Germany) at a pressure of 134.4 kPa and the transfer 
line at 300°C. Total run time was 1.5 min and the retention time for CO2 was 1.29 min 
detected once at 44.0 m/z and 9 times at 45.0 m/z with a dwell time of 10 ms each. The 
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estimated limit of detection (signal to noise ratio about 3 to 1) was about 70 times lower than 
the natural 13CO2 concentration in expiratory breath (see figure 1) even without the ninefold 
amplification. Because of the relatively high and almost constant concentrations of 13CO2 and 
12CO2 we did not identify the lower limit of detection (LLOD) exactly. 
Figure 1: Chromatographic examples for 13CO2 and 12CO2 peaks from air without (a) and with 
(b) ninefold amplification of the 13CO2 (45 m/z) signal 
 
 
 
1.10 1.20 1.30 1.40 
2000
4000
6000
Abundance 
Ion  44.00  
(43.90 to 44.10)   1.29 
1.10 1.20 1.30 1.40 
2000
4000
6000
Time [min] 
Ion  45.00 
 (44.90 to 45.10) 
  1.29 
a 
 
 
 
1 . 2 0  1 . 3 0 1 . 4 0 1 . 5 0 1 . 6
2 0 0 0 0 0
6 0 0 0 0 0
1 0 0 0 0 0 0
A b u n d a n c e I o n   4 4 . 0 0   
( 4 3 . 9 0  t o  4 4 . 1 0 ) :  
  1 . 2 9  
1 . 2 0  1 . 3 0 1 . 4 0 1 . 5 0 1 . 6
2 0 0 0 0 0
6 0 0 0 0 0
1 0 0 0 0 0 0
T i m e  [ m i n ]  
I o n   4 5 . 0 0   
( 4 4 . 9 0  t o  4 5 . 1 0 )
  1 . 2 9  
b  
 
 
 
 
 
 
Results  
First attempts in air isotope analysis without separation of the gases N2, O2, CO2 failed 
because of mass interactions from the main air components overlapped the trace amounts of 
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13CO2. An improvement of the situation could easily be achieved by assembling an adequate 
gas separation column into the GC. An other problem was the unfavourable Peak area ratio of 
the CO2 peaks of about 1:88 (13CO2 : 12CO2; natural 13C content in CO2 is about 1.12%, figure 
1a). Peaks of comparable area for 13CO2 and 12CO2 could be achieved by adapting the scan 
ratio from 1:1 (44m/z : 45m/z) to 1:9 (44m/z : 45m/z) (figure 1b). With these advanced 
conditions we analysed a couple of end expiratory breath samples. The samples were kept in 
usual glass vials and were air tight crimped prior to analysis. Repeated injections showed 
good reproducibility (Table 1) without significant changes during multiple penetration of the 
septum. 
Table 1: Preliminary tests of reproducibility with repeated air injections 
 
Series Number of 
injections 
Mean Area ratio 
(44.0m/z : 45.0 m/z))
SD Range Min Max 
1 16 1.0015472 0.004937 0.01625 0.99368 1.00993 
2 16 1.0034810 0.004925 0.01951 0.99142 1.1093 
 
 
Encouraged from these data we analysed air probes from a patient included in a study [8] 
(Patient 1) to identify base level and averaged steady state level of 13CO2 according to our 
standardized procedure (Table 2). The mean area% of 45m/z in series 0 (baseline) was 
significantly lower (p<0.05; one way ANOVA with post-hoc Dunnett-T test) than in all 
following series (150-180 min, steady state, for detailed information of the proceeding see 
[8]). The data of table 2 showed in an a priori analysis based on the results in table 1 with the 
“Gpower” software[7] that a total sample size of 8 is sufficient for identifying significant 
differences in means (alpha = 0.05, power = 0.90) 
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Table 2: Preliminary tests of air-probes from patient 1. Series 0 was collected just before 
infusion start of NaH13CO3. Series 150-180 were taken from 150 min until 180 min after start 
of infusion. The difference of means to series 0 is significant in all following series as 
indicated by the asterisk * (p<0.05). 
 
 
Series Number of 
injections 
Mean Area % of   
(45 m/z) to total  
(44m/z + 45m/z) 
SD Range Min Max 
0 8 49.419900 0.0606 0.218 49.3088  49.5268  
150* 8 49.605212 0.0727 0.220 49.4629 49.6836 
160* 8 49.569059 0.0788 0.230 49.4672 49.6979 
170* 8 49.573879 0.0607 0.185 49.5004 49.6853 
180* 8 49.591378 0.0641 0.193 49.4727 49.6660 
 
 
 
Discussion  
Multiple preparations and analysis of samples are generally used to approve the efficiency in 
accurate determination of Xenobiotics in biological material. Double determination of 
pharmaceutics in patients blood is standard as well as the coverage of an ELISA result by a 
second probe. We tried to carry the number of injections to the extreme by exhausting the 
automatic injection system with 8 injections per probe. The reproducability within one series 
(Injections out of one vial) is adequate (fig 2, table 1 and 2). We could qualitatively identify 
every enrichment of 13CO2 in our patients samples. The absolute values of the 13CO2 rise 
avoided identification by GC/MS because of the artificial multiplying of the 13CO2 signal 
along with the MS-detection without standard. For the comparison of 13CO2 enrichment 
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satisfy relative changes. As documented in the weak correlation in figure 3 the relationship 
between absolute delta values by IRMS and area percent in GC/MS 13CO2/12CO2 analysis are 
inadequate. Relative differences (averaged steady state to baseline from every patient) are to 
be fixed almost acceptable (fig 4).  
Figure 3: Comparison of absolute delta ranges from IRMS versus changes in area % of 13CO2 
to total CO2 in GC/MS runs from 54 identical patients expiratory gas samples. (data from 13 
patients prae and post op, 1 patient only post op because of leaky vials, means of steady state 
(4 times 8 injections) and baseline (8 injections)) 
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Figure 4: Comparison of  Delta values at steady state  referring to the baseline before 13C 
priming. Data from 13 patients prae and post OP, 1 patient only post OP, means of steady 
state (4 times 8 injections minus mean of baseline (8 injections)  (IRMS Delta: Difference of 
delta 13C versus V-PDB at steady state minus delta 13C versus V-PDB at baseline; GC/MS 
delta: calculated by the formula ((area% 13C at steady state/area% 13C at baseline)-1*1000) 
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Nevertheless the stability and reproducability of data obtained from the CF-IRMS is the 
unbeaten state of the art as documented by a delta 13C versus V-PDB of expected –33.68 ‰ 
and measured –33.64  ‰ (s.d 0.04 ‰) from a reference CO2 (IA-CO2-3) (International 
Atomic Energy Agency, Vienna, Austria). Corresponding 13C atom% show a 46.5 times 
smaller CV than two series of CG/MS area% analysis (table 3). Aside the quality of the MS 
systems reproducibility of the sample preparation has to be taken into account.  
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Table 3: Comparison of the CO2 QC- Data from CF-IRMS and GC-MS. IRMS data are from 
the reference gas and GC/MS data are from expiratory breath. 
 
Series Number of 
injections 
13C 
Atom% 
Mean Area % of  
(45 m/z) of total  
(44m/z + 45m/z) 
SD CV 
[%] 
CV 
mean 
ratio 
IRMS-1 13 1.074238  7.0755E-5 0.00658  
IRMS-2 9 1.074208  4.3278E-5 0.00402 
1 
GC/MS-1 16  49.9616 0.1232 0.2465 
GC/MS-2 16  49.9134 0.1230 0.2464 
46.5 
 
 
In conclusion multiple injection technique with a GC/MS system is not capable to displace 
CF-IRMS but allows an effective first glance on 13C isotope enrichment in breath analysis. 
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